Page last updated: 2024-09-03

morphiceptin and dermorphin

morphiceptin has been researched along with dermorphin in 4 studies

Compound Research Comparison

Studies
(morphiceptin)
Trials
(morphiceptin)
Recent Studies (post-2010)
(morphiceptin)
Studies
(dermorphin)
Trials
(dermorphin)
Recent Studies (post-2010) (dermorphin)
139012401239

Protein Interaction Comparison

ProteinTaxonomymorphiceptin (IC50)dermorphin (IC50)
Delta-type opioid receptorMus musculus (house mouse)0.0389
Mu-type opioid receptorRattus norvegicus (Norway rat)0.0043
Mu-type opioid receptorHomo sapiens (human)0.0018
Delta-type opioid receptorHomo sapiens (human)0.2492
Mu-type opioid receptorMus musculus (house mouse)0.0086
Mu-type opioid receptorCavia porcellus (domestic guinea pig)0.0026

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goodman, M; Ro, S; Yamazaki, T1
Goodman, M; Malmberg, AB; Ro, S; Schiller, P; Yaksh, TL1
Aoki, Y; Katao, Y; Katsumata, S; Minami, M; Nakagawa, T; Onogi, T; Satoh, M1
Goodman, M; Osapay, G; Polinsky, A; Ro, S; Yamazaki, T1

Reviews

1 review(s) available for morphiceptin and dermorphin

ArticleYear
The molecular basis of opioid potency and selectivity: morphiceptins, dermorphins, deltorphins, and enkephalins.
    NIDA research monograph, 1993, Volume: 134

    Topics: Amino Acid Sequence; Analgesics; Analgesics, Opioid; Animals; Endorphins; Humans; Molecular Sequence Data; Oligopeptides; Opioid Peptides

1993

Other Studies

3 other study(ies) available for morphiceptin and dermorphin

ArticleYear
Topochemical analysis of morphiceptin and dermorphin bioactivities.
    Biochemical and biophysical research communications, 1991, Dec-16, Volume: 181, Issue:2

    Topics: Amino Acid Sequence; Animals; Endorphins; Guinea Pigs; Ileum; Male; Mice; Molecular Conformation; Molecular Sequence Data; Oligopeptides; Opioid Peptides; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, mu; Stereoisomerism; Structure-Activity Relationship; Vas Deferens

1991
Characterization of the spinal antinociceptive activity of constrained peptidomimetic opioids.
    The Journal of pharmacology and experimental therapeutics, 1995, Volume: 275, Issue:1

    Topics: Amino Acid Sequence; Analgesia; Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Endorphins; Enkephalins; Injections, Spinal; Male; Mice; Molecular Sequence Data; Muscle, Smooth; Naloxone; Naltrexone; Narcotic Antagonists; Nociceptors; Oligopeptides; Opioid Peptides; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, mu; Spinal Cord; Structure-Activity Relationship; Vas Deferens

1995
DAMGO, a mu-opioid receptor selective ligand, distinguishes between mu-and kappa-opioid receptors at a different region from that for the distinction between mu- and delta-opioid receptors.
    FEBS letters, 1995, May-01, Volume: 364, Issue:1

    Topics: Amino Acid Sequence; Analgesics; Animals; Cells, Cultured; Endorphins; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Ligands; Molecular Sequence Data; Morphine; Naloxone; Oligopeptides; Opioid Peptides; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Recombinant Fusion Proteins; Somatostatin; Structure-Activity Relationship

1995